EMEA-001472-PIP01-13

Key facts

Active substance
  • valsartan
  • Atorvastatin
Therapeutic area
Cardiovascular diseases
Decision number
P/0231/2013
PIP number
EMEA-001472-PIP01-13
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
  • Treatment of elevated cholesterol
  • Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
GlaxoSmithKline Trading Services Limited
Ireland
Email: admin@wainwrightassociates.co.uk
Tel. +44 1628530554
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating